News
Largest TRX Holdings of Any Public Company Winter Park, Florida, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tron Inc. (Nasdaq: TRON) (the “Company”), an innovation leader at the intersection of blockchain, ...
Long-term Tron TRX holders led the token's recent sell-off to take profits. On-chain analytics platform, Glassnode, disclosed ...
Defense tech company Anduril Industries announced Tuesday that it officially entered full-scale production of solid rocket ...
On July 28 Tron Inc. filed a shelf registration statement with the SEC. The company is seeking to issue securities worth up ...
Cryptopolitan on MSN10d
MEXC Expands Stock Futures Portfolio with Tron Inc. (NASDAQ: TRON) Listing, Introducing TRON/USDT Trading Pair
MEXC, a leading global cryptocurrency exchange, has announced the listing of Tron Inc. (NASDAQ: TRON) Stock Futures, ...
13d
Cryptopolitan on MSNTRON (TRX) Overtakes Cardano (ADA) in Market Cap, Yet This Token Could Overtake Both by 2026
As TRON (TRX) pushes past Cardano (ADA) in market capitalization, it becomes clear that the battle among Layer-1 block ...
TRX overbought RSI suggests a potential cooldown as TRON gains attention from its Nasdaq debut. Key support levels and RSI ...
Hosted on MSN13d
Tron files with SEC to issue $1B in mixed shelf offering
Founded by Justin Sun in 2017, Tron Inc. is a blockchain company that went public on July 24, following a reverse merger with Nasdaq-listed SRM Entertainment. It recently turned to the crypto treasury ...
Tron Inc., formerly SRM Entertainment, aims to raise $1 billion to increase TRX reserves. The firm leads as the largest TRX ...
(RTTNews) - Forbo reported first half profit of 33.4 million Swiss francs compared to 48.4 million Swiss francs, prior year. Operating profit before depreciation and amortization or EBITDA was 67. ...
Tron (CRYPTO: TRX) was trading higher Monday night, defying the broader decline in the cryptocurrency market after Tron Inc. ...
(RTTNews) - Apellis Pharmaceuticals Inc. (APLS) announced that the U.S. Food and Drug Administration has approved EMPAVELI (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results